hVIVO PLC (HVO)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

5.10p

Buy

5.40p

arrow-up0.46p (+9.58%)

Prices updated at 12 Dec 2025, 17:15 GMT

Prices minimum 15 mins delay

Prices in GBX

Venn Life Sciences Holdings PLC is engaged into a Clinical Research Organisation (CRO) providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

-

CEO

Mr. Yamin Mohammed Khan

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

299

Head office

40 Bank Street

London

United Kingdom

E14 5NR

-

info@venncro.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Professor Brendan Buckley Non-Executive Director	-
Mr. Stephen Pinkerton Executive Director, Chief Financial Officer	-
Mr. Yamin Mohammed Khan Executive Director, Chief Executive Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
JP Morgan Asset Management (UK) Ltd	27,430,000
JPMorgan UK Small Cap Growth & Income	19,070,000
Octopus Investments Limited	15,300,000
FP Octopus UK Micro Cap Growth Fund	14,000,000
FIL Investment Services (UK) Ltd	13,222,347

Director dealings

Date chevron-l-regular chevron-r-regular	Action
10 Apr 2025	Exercise of Option
13 Mar 2025	Exercise of Option
13 Mar 2025	Sale of Option

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.